z-logo
open-access-imgOpen Access
Structural and Functional Diversity of Resistance–Nodulation–Cell Division Transporters
Author(s) -
Philip A. Klenotic,
Mitchell A. Moseng,
Christopher E. Morgan,
Edward Yu
Publication year - 2020
Publication title -
chemical reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 20.528
H-Index - 700
eISSN - 1520-6890
pISSN - 0009-2665
DOI - 10.1021/acs.chemrev.0c00621
Subject(s) - efflux , chemistry , bacterial cell structure , antibiotic resistance , multiple drug resistance , antibiotics , cell membrane , bacteria , microbiology and biotechnology , cell , biology , biochemistry , genetics
Multidrug resistant (MDR) bacteria are a global threat with many common infections becoming increasingly difficult to eliminate. While significant effort has gone into the development of potent biocides, the effectiveness of many first-line antibiotics has been diminished due to adaptive resistance mechanisms. Bacterial membrane proteins belonging to the resistance-nodulation-cell division (RND) superfamily play significant roles in mediating bacterial resistance to antimicrobials. They participate in multidrug efflux and cell wall biogenesis to transform bacterial pathogens into "superbugs" that are resistant even to last resort antibiotics. In this review, we summarize the RND superfamily of efflux transporters with a primary focus on the assembly and function of the inner membrane pumps. These pumps are critical for extrusion of antibiotics from the cell as well as the transport of lipid moieties to the outer membrane to establish membrane rigidity and stability. We analyze recently solved structures of bacterial inner membrane efflux pumps as to how they bind and transport their substrates. Our cumulative data indicate that these RND membrane proteins are able to utilize different oligomerization states to achieve particular activities, including forming MDR pumps and cell wall remodeling machineries, to ensure bacterial survival. This mechanistic insight, combined with simulated docking techniques, allows for the design and optimization of new efflux pump inhibitors to more effectively treat infections that today are difficult or impossible to cure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom